Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts

Fig. 3

Venn diagram of features indicative of ICS usage among ICS users in 2017 Of the 444 ICS users in 2017, 175 (39.4%) had a history of asthma, 90 (20.2%) had blood eosinophilia, and 51 (11.5%) had experienced more than two exacerbations in the year prior to enrollment. Of the 211 (47.5%) patients who had no feature supporting ICS usage, 23 (10.9%) satisfied the bronchodilator response. BDR = bronchodilator response; FEV1 = forced expiratory volume in 1 s; ICS = Inhaled corticosteroid. n = 315

Back to article page